Autism risk spotted in abnormal placentas

Researchers at the Yale School of Medicine found that abnormal placentas may be able to help diagnose risk for autism in newborns.

“Kliman and his team examined 117 placentas from infants of at-risk families, those with one or more previous children with autism. These families were participating in a study called Markers of Autism Risk in Babies – Learning Early Signs. Kliman compared these at-risk placentas to 100 control placentas collected by the UC Davis researchers from the same geographic area.

The at-risk placentas had as many as 15 trophoblast inclusions, while none of the control placentas had more than two trophoblast inclusions. Kliman said a placenta with four or more trophoblast inclusions conservatively predicts an infant with a 96.7% probability of being at risk for autism.” (source)

This sounds like very promising information. If these markers can be identified at the very beginning of a child’s life there is valuable time saved when it comes to treatment. Children are not typically diagnosed with autism until 2 or 3 years of age. These markers in the placenta allow children with noted increased risk to receive earlier intervention and services during the year when their brain is most receptive to treatment.

While this is most certainly out of the scope of placenta encapsulation specialists to identify it is fascinating information nonetheless.

Like this:

Footer

This site is for informational purposes only. It does not intend to treat, cure, or prevent any disease. Do not use this information for diagnosis or treatment purposes, or against the advice of your medical practitioner. Always consult your doctor or practitioner for any health-related issues you may be experiencing. Statements regarding dietary supplements have not been evaluated by the FDA.